[go: up one dir, main page]

MX167185B - Procedimiento de obtencion de una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico - Google Patents

Procedimiento de obtencion de una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico

Info

Publication number
MX167185B
MX167185B MX011281A MX1128188A MX167185B MX 167185 B MX167185 B MX 167185B MX 011281 A MX011281 A MX 011281A MX 1128188 A MX1128188 A MX 1128188A MX 167185 B MX167185 B MX 167185B
Authority
MX
Mexico
Prior art keywords
fat
granule
pharmaceutical product
composition
depositing
Prior art date
Application number
MX011281A
Other languages
English (en)
Inventor
Jaakko Uotila
Esko Marttila
Ilkka Larma
Kari Vahervuo
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of MX167185B publication Critical patent/MX167185B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a procedimiento de obtención de una composición para depositarse sobre la superficie d eun gránulo de un producto farmacéutico, en donde el producto farmacéutico está destinado a dosificarse especialmente en forma de un polvo, introducido en cápsulas o en forma de una mezcla, cuya composición está constituída por al menos 3 capas, de las cuales la más interna consiste en una grasa substancialmente pura, la intermedia en una mezcla de grasa y polímero y la más externa de nuevo en una grasa substancialmente pura; caracterizado porque la grasa/mezcla de grasa y polímero/grasa, disueltas en un disolvente orgánico, se depositan sobre el gránulo farmacéutico según los principios de la técnica de lecho fluidificado.
MX011281A 1987-05-08 1988-04-27 Procedimiento de obtencion de una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico MX167185B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI872051A FI77573C (fi) 1987-05-08 1987-05-08 Ny konsistens.

Publications (1)

Publication Number Publication Date
MX167185B true MX167185B (es) 1993-03-09

Family

ID=8524451

Family Applications (1)

Application Number Title Priority Date Filing Date
MX011281A MX167185B (es) 1987-05-08 1988-04-27 Procedimiento de obtencion de una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico

Country Status (35)

Country Link
US (1) US4935247A (es)
JP (1) JPS63287720A (es)
KR (1) KR880013551A (es)
AT (1) AT396329B (es)
AU (1) AU610161B2 (es)
BE (1) BE1000785A3 (es)
CH (1) CH675070A5 (es)
CS (1) CS270588B2 (es)
DD (1) DD284600A5 (es)
DE (1) DE3815562A1 (es)
DK (1) DK247588A (es)
EG (1) EG18603A (es)
ES (1) ES2006649A6 (es)
FI (1) FI77573C (es)
FR (1) FR2630912B1 (es)
GB (1) GB2204241B (es)
GR (1) GR1000303B (es)
HU (1) HU198621B (es)
IL (1) IL86313A (es)
IS (1) IS3339A7 (es)
IT (1) IT1219691B (es)
LU (1) LU87208A1 (es)
MA (1) MA21264A1 (es)
MX (1) MX167185B (es)
NL (1) NL8801185A (es)
NO (1) NO881993L (es)
NZ (1) NZ224529A (es)
PH (1) PH24652A (es)
PL (1) PL272295A1 (es)
PT (1) PT87429B (es)
RO (1) RO101402B (es)
RU (1) RU1836082C (es)
SE (1) SE8801732L (es)
YU (1) YU46457B (es)
ZA (1) ZA883239B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01299226A (ja) * 1988-05-27 1989-12-04 Seikagaku Kogyo Co Ltd サラゾスルファピリジン腸溶顆粒
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5055307A (en) * 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5093128A (en) * 1989-07-18 1992-03-03 Draguesku Oliver J Rumen and other stomach chamber bypass nutrients and methods of fabrication
JP3078859B2 (ja) * 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
EP0689840A1 (de) * 1994-06-28 1996-01-03 Spirig Ag Pharmazeutische Präparate Neues orales Erythromycinbase enthaltendes Arzneimittel
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US6242019B1 (en) 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
AU2006253006B8 (en) * 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
ES2607988T3 (es) * 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
BRPI0808391A2 (pt) 2007-02-01 2014-07-08 Lams Company Método para diminuir a inflamação e o estresse em um mamífero, mediante o uso de antimetabólitos de glicose, abacate ou extratos de abacate.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE835500C (de) * 1950-05-18 1952-03-31 Otto Doerr Dipl Ing Verfahren zum Konservieren eines in einem indifferenten Koerper gespeicherten, im Darm zur Wirkung zu bringenden Mittels
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
GB821790A (en) * 1956-11-20 1959-10-14 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
NL122039C (es) * 1960-10-20
BE636568A (es) * 1961-01-31
BE640616A (es) * 1962-12-19
US3256153A (en) * 1963-02-08 1966-06-14 Smith Kline French Lab Method of stabilizing wax-fat coating materials and product thereof
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
ATE109659T1 (de) * 1986-03-21 1994-08-15 Eurasiam Lab Arzneimittelzusammensetzungen.

Also Published As

Publication number Publication date
SE8801732L (sv) 1988-11-09
RO101402B (ro) 1992-01-13
SE8801732D0 (sv) 1988-05-06
HUT48458A (en) 1989-06-28
KR880013551A (ko) 1988-12-21
NL8801185A (nl) 1988-12-01
NO881993D0 (no) 1988-05-06
PH24652A (en) 1990-09-07
GB2204241A (en) 1988-11-09
BE1000785A3 (fr) 1989-04-04
ATA119188A (de) 1992-12-15
GB8810765D0 (en) 1988-06-08
ZA883239B (en) 1989-07-26
IS3339A7 (is) 1988-08-31
FI77573C (fi) 1989-04-10
CS310288A2 (en) 1989-11-14
NZ224529A (en) 1990-02-26
PT87429A (pt) 1989-05-31
RU1836082C (ru) 1993-08-23
AU1567288A (en) 1988-11-10
HU198621B (en) 1989-11-28
ES2006649A6 (es) 1989-05-01
IL86313A (en) 1991-08-16
JPS63287720A (ja) 1988-11-24
EG18603A (en) 1993-06-30
US4935247A (en) 1990-06-19
DK247588D0 (da) 1988-05-06
AT396329B (de) 1993-08-25
CS270588B2 (en) 1990-07-12
PL272295A1 (en) 1989-11-13
GR1000303B (el) 1992-05-12
AU610161B2 (en) 1991-05-16
IT8820479A0 (it) 1988-05-06
GR880100297A (en) 1989-02-23
FR2630912B1 (fr) 1991-04-12
DE3815562A1 (de) 1988-11-24
DK247588A (da) 1988-11-09
IL86313A0 (en) 1988-11-15
YU46457B (sh) 1993-10-20
FR2630912A1 (fr) 1989-11-10
IT1219691B (it) 1990-05-24
NO881993L (no) 1988-11-09
CH675070A5 (es) 1990-08-31
FI872051L (fi) 1988-11-09
GB2204241B (en) 1991-02-20
MA21264A1 (fr) 1988-12-31
FI77573B (fi) 1988-12-30
YU83188A (en) 1989-12-31
DD284600A5 (de) 1990-11-21
PT87429B (pt) 1992-09-30
LU87208A1 (fr) 1988-12-13
FI872051A0 (fi) 1987-05-08

Similar Documents

Publication Publication Date Title
MX167185B (es) Procedimiento de obtencion de una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico
EP3173100B1 (en) Therapeutic combination comprising a cdks inhibitor and oxaliplatin
JP2002532550A (ja) がん治療のためのファルネシルトランスフェラーゼ阻害剤およびイリノテカンもしくはカンプトテカンの組み合わせ物。
AR100473A2 (es) Un método para la manufactura de una preparación para administración oral
NO841518L (no) Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
MX2008014824A (es) Pirazolo[1,5-a]pirimidinas como inhibidores de quinasas dependientes de ciclina.
ATE66141T1 (de) Pharmazeutische zusammensetzung.
MX9304611A (es) Clohidrato de triazoliltiometiltio cefalosporina, su hidrato cristalino y proceso para su preparacion.
GR3036792T3 (en) New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments.
JPS5925316A (ja) 作用時間の長いスロ−・リリ−ズ薬剤組成物及びその製法
ES2106875T3 (es) Procedimiento para preparar sustancias farmacologicas en forma de perla.
KR20100137572A (ko) 발데나필 하이드로클로라이드 삼수화물을 포함하는 약물
ES2187234A1 (es) Forma de dosificacion oral para tratar la disfuncion sexual.
ES2057225T3 (es) Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion.
HUT49450A (en) Insecticides and acaricides containing as active substance derivatives of 2,2 difluor cycloprophil ethan and process for production of the active substance
DE69113976D1 (de) Verfahren zur galenischen herstellung eines therapeutischen mittels, insbesondere auf aspirinbasis.
AU4885685A (en) 4-Alkoxy-pyrido (2,3-d) pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them
US11884670B1 (en) Pyrido[4′,3′:4,5]pyrrolo[3,2-c][2,7]naphthyridin-10-one compounds as CK2 inhibitors
US11891397B1 (en) Pyrido[4′,3′:4,5]pyrrolo[3,2-c][1,7]naphthyridin-10-one compounds as CK2 inhibitors
ES2036609T3 (es) Granulado exento de aglutinante con lubricacion retardada del producto activo.
JPH03502097A (ja) Ｐａｆ拮抗薬‐抗ヒスタミン剤の組合せ及び使用方法
FR2368272A1 (fr) Compositions therapeutiques solides pour combattre l'agregation plaquettaire
IE36563B1 (en) New diazepine derivatives and processes for their production
MY8100371A (en) 5-(2-foroyl)-,5-(2-thenoyl)-,5-(3-furoyl)-and 5-(3-thenoyl)-1,2-dihydro-3h-pyrrolo [1,2-a)pyrrole-1-carboxylic acid derivatives and process for the production thereof